Document Detail

Efficacy in angiotensin receptor blockade: a comparative review of data with olmesartan.
MedLine Citation:
PMID:  19651759     Owner:  NLM     Status:  MEDLINE    
A range of angiotensin II receptor blockers (ARB) is available, and analyses suggest there are differences between agents in terms of antihypertensive efficacy and 24-hour blood pressure control.This review assesses the data comparing olmesartan with other ARBs in terms of blood pressure reductions, goal achievement, 24-hour control and speed of onset. Olmesartan seems to have a more favourable efficacy profile relative to standard doses of the ARBs used in comparative studies; results consistent with the high degree of blockade of the angiotensin II type 1 receptor for olmesartan.Taken together, there might be differences between ARBs regarding their blood pressure lowering efficacy, and these results may provide further support of the benefits of olmesartan therapy since choice of an effective agent is crucial in antihypertensive therapy.
Josep Redon; Maria Jose Fabia
Related Documents :
9824519 - Comparing standard care with a physician and pharmacist team approach for uncontrolled ...
7973239 - Median analysis of blood pressure for a sample including treated hypertensives.
8622249 - Choice of initial therapy for hypertension.
15536209 - Translating research into practice: are physicians following evidence-based guidelines ...
8503429 - What effect does blood pressure control have on the progression toward renal failure?
15663349 - Postural blood pressure changes and orthostatic hypotension in the elderly patient: imp...
7451649 - Influence of prostaglandin synthesis inhibitors on pulmonary vasodilatory effects of hy...
7403339 - 16, 16 dimethyl pge2: evidence that it has properties different from the parent compoun...
24290869 - Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirr...
Publication Detail:
Type:  Comparative Study; Journal Article; Review     Date:  2009-08-03
Journal Detail:
Title:  Journal of the renin-angiotensin-aldosterone system : JRAAS     Volume:  10     ISSN:  1752-8976     ISO Abbreviation:  J Renin Angiotensin Aldosterone Syst     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-08-28     Completed Date:  2010-02-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100971636     Medline TA:  J Renin Angiotensin Aldosterone Syst     Country:  England    
Other Details:
Languages:  eng     Pagination:  147-56     Citation Subset:  IM    
Hypertension Clinic, Hospital Cl??nico Universitario, University of Valencia, Valencia, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Pressure / drug effects
Drug Therapy, Combination
Imidazoles / chemistry,  pharmacology*
Receptors, Angiotensin / antagonists & inhibitors*,  chemistry
Tetrazoles / chemistry,  pharmacology*
Treatment Outcome
Reg. No./Substance:
0/Imidazoles; 0/Receptors, Angiotensin; 0/Tetrazoles; 0/olmesartan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty l...
Next Document:  Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor bloc...